To order this detailed 180+ page report, please visit this -
https://www.rootsanalysis.com/reports/view_document/peptides-and-macrocycle-discovery/300.html
Key Inclusions
§
A detailed assessment of the current market landscape of
companies offering peptide and macrocycle drug discovery services, including
developer information (year of establishment, company size and location of
headquarters), type of peptide manufactured (linear, cyclic, helical and
others), drug discovery steps covered in service portfolio (target validation,
hit identification, lead generation and lead optimization), peptide generation
methods used (liquid phase synthesis, solid phase synthesis, microwave-assisted
synthesis, recombinant methods and others), peptide modification services
(C-terminal, N-terminal, fret / quenching tags, immunogenic conjugates, linkers
/ spacers, unnatural AAS, cyclization, stable isotope labels and
post-translational modification services) and other services offered (peptide
isolation / purification service, peptide detection / identification service
and peptide quantification service).
§
An insightful geographical benchmarking of the capabilities
of companies of various sizes, highlighting the key focus areas, comparing
their existing strengths both within and beyond their respective peer groups
(based on geography and company size).
§
An in-depth analysis of peptide platform and library
service providers, featuring information on their company details (year of
establishment, company size and location of headquarters), purpose of the
platform, type of peptide manufactured (linear, cyclic, helical and others) and
platform access model (pipeline licensing, technology licensing, strategic
alliance and library provider).
§
Profiles of peptides
and macrocycle drug discovery service providers, featuring information on the
year of establishment, location of headquarters, peptide discovery service /
platform portfolio, recent developments, and an informed future outlook.
§
An analysis of the
partnerships that have been established in the recent past, covering mergers
and acquisitions, research collaborations, R&D agreements, licensing
agreements (related to both technology platforms and service providers) and
other form of collaborations.
§
An analysis of proprietary display technologies developed
by different drug discovery technology providers, based on the 2X2 matrix.
§
Informed estimates of
the existing market size and the future opportunity for peptides and macrocycle
drug discovery service and platform providers, over the next decade. Based on
multiple parameters, such as total pharmaceutical R&D market, biological
pipeline, peptide drugs pipeline and drug discovery outsourcing percentage, we
have provided informed estimates on the evolution of the market for the period
2020-2030.
The report also features the likely
distribution of the current and forecasted opportunity across important market
segments, mentioned below:
§ Type
of peptides
§ Synthetic
peptides
§ Biologic
and recombinant peptides
To Request for sample -
https://www.rootsanalysis.com/reports/303/request-sample.html
§ Type
of discovery steps
§
Target identification and validation
§
Hit identification
§
Lead generation
§
Lead optimization
§
Therapeutic Area
§
Oncological disorders
§
Metabolic disorders
§
Cardiovascular disorders
§
Infectious diseases
§
Urological disorders
§
Endocrine disorders
§
CNS disorders
§
Other diseases
§
Company Size
§
Small companies
§
Mid-sized companies
§
Large and very large companies
§ Key
geographical regions
§ Europe
§ North
America
§ Asia-Pacific
and the Rest of the World
To request sample pages, please visit this https://www.rootsanalysis.com/reports/300/request-sample.html
Key Questions Answered
§
Who are the key service providers for peptide discovery?
§
Who are the key service providers for macrocycle drug discovery?
§
Who are the service providers that can synthesize peptide
and macrocycle libraries?
§
What is the outsourcing trend in the peptides and
macrocycle drug discovery?
§
How is the current and future market opportunity likely to
be distributed across key market segments based on the services market?
§
What are the promising technology platforms that are
available for the discovery of peptides and macrocyclic drugs?
§
What are the various trends in partnerships and licensing
activity in this domain?
§
What are the strengths, weakness, opportunities, and
threats in this industry?
You may also be interested in the following titles:
1.
1DNA-Encoded Libraries: Platforms and
Services Market, 2020–2030
2.
Antibody Contract
Manufacturing
Market, 2020 – 2030
3.
Global Autoinjectors
Market,
2020-2030
About Roots Analysis
Roots Analysis is one of the fastest growing
market research companies, sharing fresh and independent perspectives in the
bio-pharmaceutical industry. The in-depth research, analysis and insights are
driven by an experienced leadership team which has gained many years of
significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Details
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com
Roots Analysis
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com
Medium: https://medium.com/@RootsAnalysis
Pinterest: https://in.pinterest.com/RootsanalysisPin/_saved/
Quora: https://rootsanalysisinsights.quora.com/
